Findings reported in JAMA Network Open don’t find racial disparities among those who meet the treatment criteria. But Black individuals were less likely than Asian or White individuals to be among those meet the criteria.
Robert Calandra
Advertisement
Articles by Robert Calandra
In the 3 cases documented by researchers, hepatitis B surface antigen (HBsAG) levels were reduced by more than 50% after Japan began its COVID-19 vaccination program.
A trio of leading hepatitis researchers survey the treatments in development for chronic hepatitis B. They end on a high note: That for the first time in 20 years, a cure is in sight.
Advertisement
Latest Updated Articles
Why Is There Such A Large Disparity In Who Meets Critera For Hepatitis B Treatment?Published: May 10th 2023 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Q&A: The Initiative Bringing Clinical Pharmacy Care to Underserved Patients’ Homes
2
Pharmacists Reimagine the Future of Pharmacy
3
Investigators Evaluate Decline in Percentage of Patients With COPD Using Inhaled Corticosteroids
4
Naloxone Sales Highlight Limited OTC Use, Access Challenges
5
